{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:25:16Z","timestamp":1769109916286,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.cjca.2014.05.004","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T09:31:55Z","timestamp":1399627915000},"page":"1216-1224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Patent Foramen Ovale Closure vs Medical Therapy for Stroke Prevention: Meta-analysis of Randomized Trials and\u00a0Review of Heterogeneity in Meta-analyses"],"prefix":"10.1016","volume":"30","author":[{"given":"Jacob A.","family":"Udell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander R.","family":"Opotowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Khairy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candice K.","family":"Silversides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Gladstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick T.","family":"O\u2019Gara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Landzberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2014.05.004_bib1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/STR.0b013e3181fcb238","article-title":"Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Goldstein","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2014.05.004_bib2","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1161\/STR.0b013e31825bcdac","article-title":"Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"43","author":"Lackland","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2014.05.004_bib3","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1161\/STROKEAHA.112.668319","article-title":"Utility of Framingham coronary heart disease risk score for predicting cardiac risk after stroke","volume":"43","author":"Towfighi","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2014.05.004_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/STR.0b013e3181f7d043","article-title":"Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Furie","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2014.05.004_bib5","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.05.004_bib6","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMcp043981","article-title":"Patent foramen ovale in young adults with unexplained stroke","volume":"353","author":"Kizer","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.05.004_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0025-6196(12)60336-X","article-title":"Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts","volume":"59","author":"Hagen","year":"1984","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cjca.2014.05.004_bib8","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/01.STR.19.9.1083","article-title":"The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke","volume":"19","author":"Bogousslavsky","year":"1988","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2014.05.004_bib9","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM198805053181802","article-title":"Prevalence of patent foramen ovale in patients with stroke","volume":"318","author":"Lechat","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.05.004_bib10","doi-asserted-by":"crossref","first-page":"922","DOI":"10.7326\/0003-4819-117-11-922","article-title":"Transesophageal echocardiography in the evaluation of stroke","volume":"117","author":"DeRook","year":"1992","journal-title":"Ann Int Med"},{"key":"10.1016\/j.cjca.2014.05.004_bib11","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJMoa011503","article-title":"Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both","volume":"345","author":"Mas","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.05.004_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.59.1.26","article-title":"Clinical outcome in 287 consecutive young adults (15 to 45 years) with ischemic stroke","volume":"59","author":"Leys","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.cjca.2014.05.004_bib13","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1056\/NEJMoa071422","article-title":"Patent foramen ovale and cryptogenic stroke in older patients","volume":"357","author":"Handke","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.cjca.2014.05.004_bib14","first-page":"S26","article-title":"Is patent foramen ovale a modifiable risk factor for stroke recurrence?","volume":"41","author":"Kent","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2014.05.004_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/hrt.2003.019315","article-title":"Indications for the closure of patent foramen ovale","volume":"90","author":"Landzberg","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2014.05.004_bib16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-139-9-200311040-00010","article-title":"Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review","volume":"139","author":"Khairy","year":"2003","journal-title":"Ann Int Med"},{"key":"10.1016\/j.cjca.2014.05.004_bib17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcin.2012.02.021","article-title":"Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism","volume":"5","author":"Agarwal","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2014.05.004_bib18","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/STROKEAHA.111.631648","article-title":"Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence","volume":"43","author":"Kitsios","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2014.05.004_bib19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/jama.299.5.521","article-title":"Trends in the use of percutaneous closure of patent foramen ovale and atrial septal defect in adults, 1998-2004","volume":"299","author":"Opotowsky","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2014.05.004_bib20","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.05.004_bib21","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Carroll","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.05.004_bib22","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.05.004_bib23","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2014.05.004_bib24","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2014.05.004_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.cjca.2014.05.004_bib26","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.amjcard.2007.12.040","article-title":"Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer cersus CardioSEAL-STARflex cersus Helex Occluder)","volume":"101","author":"Taaffe","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2014.05.004_bib27","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/CIRCULATIONAHA.107.727271","volume":"117","author":"Dowson","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.05.004_bib28","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/STROKEAHA.107.181486","volume":"38","author":"Adams","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2014.05.004_bib29","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","article-title":"Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"44","author":"Jauch","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2014.05.004_bib30","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0735-1097(85)80228-X","article-title":"Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases","volume":"6","author":"Hanley","year":"1985","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.05.004_bib31","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1161\/01.CIR.91.11.2785","article-title":"Atrial septal aneurysm in adult patients: a multicenter study using transthoracic and transesophageal echocardiography","volume":"91","author":"M\u00fcgge","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.05.004_bib32","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1161\/01.CIR.99.15.1942","article-title":"Frequency of atrial septal aneurysms in patients with cerebral ischemic events","volume":"99","author":"Agmon","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.05.004_bib33","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1212\/WNL.55.8.1172","article-title":"Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies","volume":"55","author":"Overell","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.cjca.2014.05.004_bib34","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0735-1097(03)00907-0","article-title":"Atrial anatomy in non-cardioembolic stroke patients. Effect of medical therapy","volume":"42","author":"Homma","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.05.004_bib35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1745-6215-12-185","article-title":"The Risk of Paradoxical Embolism (RoPE) study: developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke","volume":"12","author":"Kent","year":"2011","journal-title":"Trials"},{"key":"10.1016\/j.cjca.2014.05.004_bib36","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/CIRCOUTCOMES.112.966176","article-title":"Percutaneous closure of patent foramen ovale: a near-perfect treatment ruined by careful study?","volume":"5","author":"Kent","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cjca.2014.05.004_bib37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/clc.22008","article-title":"Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 trial","volume":"35","author":"Kandzari","year":"2012","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cjca.2014.05.004_bib38","first-page":"74","article-title":"Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter","volume":"27","author":"Cairns","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2014.05.004_bib39","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1093\/eurheartj\/eht285","article-title":"Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials","volume":"34","author":"Rengifo-Moreno","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2014.05.004_bib40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.hlc.2013.12.003","article-title":"Amplatzer PFO occluder device may prevent recurrent stroke in patients with patent foramen ovale and cryptogenic stroke: a meta-analysis of randomised trials","volume":"23","author":"Pandit","year":"2014","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.cjca.2014.05.004_bib41","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jcin.2013.08.001","article-title":"Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke","volume":"6","author":"Khan","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2014.05.004_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijcard.2013.08.058","article-title":"PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis","volume":"169","author":"Ntaios","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2014.05.004_bib43","first-page":"968","article-title":"A\u00a0meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events","volume":"82","author":"Pineda","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2014.05.004_bib44","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2261-13-116","article-title":"Transcatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: a meta-analysis of randomized clinical trials","volume":"13","author":"Riaz","year":"2013","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cjca.2014.05.004_bib45","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1161\/STROKEAHA.113.001773","article-title":"Potentially large yet uncertain benefits: a meta-analysis of patent foramen ovale closure trials","volume":"44","author":"Kitsios","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2014.05.004_bib46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/heartjnl-2013-304394","article-title":"Stroke prevention by percutaneous closure of patent foramen ovale: a systematic review and meta-analysis","volume":"100","author":"Wolfrum","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2014.05.004_bib47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.carrev.2013.08.010","article-title":"Safety and efficacy of device closure for patent foramen ovale for secondary prevention of neurological events: comprehensive systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Hakeem","year":"2013","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.cjca.2014.05.004_bib48","doi-asserted-by":"crossref","first-page":"e004282","DOI":"10.1136\/bmjopen-2013-004282","article-title":"Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale","volume":"4","author":"Spencer","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.cjca.2014.05.004_bib49","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1016\/j.ijcard.2013.07.077","article-title":"Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials","volume":"168","author":"Kwong","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2014.05.004_bib50","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.hlc.2013.07.022","article-title":"Is transcatheter closure better than medical therapy for cryptogenic stroke with patent foramen ovale? A meta-analysis of randomised trials","volume":"22","author":"Nagaraja","year":"2013","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.cjca.2014.05.004_bib51","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.4244\/EIJV9I11A225","volume":"9","author":"Capodanno","year":"2014","journal-title":"EuroIntervention"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14003250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14003250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:38:02Z","timestamp":1760107082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X14003250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0828282X14003250"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2014.05.004","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patent Foramen Ovale Closure vs Medical Therapy for Stroke Prevention: Meta-analysis of Randomized Trials and\u00a0Review of Heterogeneity in Meta-analyses","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2014.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}